General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -0.21 | -0.31 | -0.1 | -47.62% |
2024-03-14 | 2023-12 | 0 | -0.5 | N/A | N/A |
2024-03-14 | 2023-12 | 0 | N/A | N/A | N/A |
2023-11-09 | 2023-09 | -0.29 | N/A | N/A | N/A |
2023-11-09 | 2023-09 | -0.29 | -0.2 | 0.09 | 31.03% |
2023-08-10 | 2023-06 | -0.24 | -0.31 | -0.07 | -29.17% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-05-14 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-03-19 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-02-22 | HC Wainwright & Co. | Upgrade | Buy | |
2022-11-13 | HC Wainwright & Co. | Upgrade | Buy | |
2022-08-14 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-05-23 | BENSON REED L | General Counsel | 3.17K | Conversion of Exercise of derivative security |
2023-11-21 | BROWN BRIAN LEE | Chief Financial Officer | 213.22K | Stock Award(Grant) |
2023-11-21 | DURENARD EUGENE A | Director | 85.00K | Stock Award(Grant) |
2023-11-21 | EGAN DWIGHT H | Chief Executive Officer | 270.88K | Stock Award(Grant) |
2023-11-21 | MURPHY TED | Director | 97.50K | Stock Award(Grant) |
2023-11-21 | NELSON JAMES B | Director | 85.00K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.78M | 1.98M | 5.79% |
2023-06-29 | Renaissance Technologies, LLC | 653.70K | 725.61K | 2.12% |
2023-06-29 | Blackrock Inc. | 506.51K | 562.22K | 1.65% |
2023-06-29 | Geode Capital Management, LLC | 302.16K | 335.39K | 0.98% |
2023-06-29 | Bridgeway Capital Management, Inc. | 272.90K | 302.92K | 0.89% |
2023-06-29 | Bank Of New York Mellon Corporation | 145.62K | 161.64K | 0.47% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.28M | 1.42M | 4.15% |
2023-06-29 | Vanguard Extended Market Index Fund | 444.78K | 493.70K | 1.44% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Fund | 272.90K | 302.92K | 0.89% |
2023-05-30 | Fidelity Extended Market Index Fund | 165.22K | 180.09K | 0.54% |
2023-08-30 | iShares Micro Cap ETF | 69.84K | 86.60K | 0.23% |
2023-05-30 | Fidelity Total Market Index Fund | 53.59K | 58.41K | 0.17% |
$CODX wont be long before this shows up on ‘value’ stock funds radar, imo. Probable 6 trailing p/e by April. Bipolar momentum market making for dangerous valuation dispersions.
$CODX new theme song: We Didnt Start The Fire -Billy Joel
$CODX maybe go private, spin off a SPAQ, then merge with itself at 10x todays price. Sheesh
$CODX bought a new pet snail today. Debating names..Maybe Cody?
$CODX strange to see this go from hyper growth stock to value stock within 3 months. Inclusion in Russell 2000 this quarter. No debt, tons of cash in hand now. Dependable revenue stream. No updates from mgt. odd.
$CODX shorts are in control
It’s difficult to see a company fighting covid so effectively be beaten down. Co-diagnostics provides CRL with their rapid response covid test. All LA schools are being tested using this test.
$CODX great job Sameer. You’re the Mason to my Perry.
Who’s heard of either America 2030 Capital? Or Bentley-Rothschild?
@Rico_F great point
$CODX its all shaping up for January for sentiment to shift: “Meanwhile, the president-elect chose Carole Johnson, the commissioner of New Jersey's human services department and a former senior health adviser in the Obama-Biden White House, as the nation's new Covid-19 testing coordinator. Johnson, who worked on strategies to fight the Ebola and Zika epidemics as a member of the White House Domestic Policy Council's health team, will focus on expanding tests in schools, nursing homes and other settings — and for high-risk populations that have been hit hard by the pandemic.”
https://www.politico.com/news/2020/12/29/biden-coronavirus-response-coordinators-451996
$CODX https://www.thedenverchannel.com/news/coronavirus/colorado-officials-identify-first-case-of-covid-19-variant-seen-in-uk (FYI, CSU’s lab uses the Thermo-Fisher Taqpac PCR test assay)
“The state said its lab was the first in the country to identify the new variant. A PCR test done on the sample DID NOT find a so-called “S gene” signal, which officials say is a signature for the variant of COVID-19.
Scientists then sequenced the genome from the man in Elbert County’s sample and found eight mutations that the Colorado Department of Health and Environment say are specific to the variant’s signature spike protein.”
$CODX According to news it was at Colorado state lab. Their lab uses Thermo Fisher PCR test assay. But I did find this interesting:
https://www.independent.co.uk/news/world/americas/uk-covid-variant-colorado-b1780145.html
“Colorado health officials did not initially identify the presence of Covid-19 through a routine diagnostic PCR test. The sample was flagged for investigation, and researchers determined the viral genome contained eight mutations “specific to the spike protein gene associated with this variant,” according to the governor’s office.”
$CODX http://csu-cvmbs.colostate.edu/vdl/Pages/SARS-CoV-2-testing-information.aspx. It’s Thermo-Fisher’s TaqPath PCR
http://csu-cvmbs.colostate.edu/vdl/Pages/SARS-CoV-2-testing-information.aspx. It’s the Thermo-Fischer TaqPath PCR.
$CODX https://twitter.com/govofco?lang=en
So, it was PCR test that detected it. Wonder whose test?
$CODX Never short a dull stock 🛻. Put it right there in the cargo bed fellas
Value stock now. Singing a bedtime lullaby until January.
Bearish trend. Needs a close above 50 day EMA to even try a reversal. Until then, more pain